WHO ICTRP trial
A phase III study of Actos combination drug in diabetic patients
JPRN-jRCT2080220870 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220870 |
|---|---|
| Public title | A phase III study of Actos combination drug in diabetic patients |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Diabetes mellitus |
| Interventions | investigational material(s) Generic name etc : Actos combination drug INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral administration |
| Registration date | Sep 24, 2009 |
| Secondary IDs | JapicCTI-090901 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: